Second-site mutation in the Wiskott-Aldrich syndrome (WAS) protein gene causes somatic mosaicism in two WAS siblings

Journal of Clinical Investigation

Volumn 111, Issue 9, 2003, Pages 1389-1397

  Wada, Taizo ^a,c   Konno, Akihiro ^a   Schurman, Shepherd H ^a   Garabedian, Elizabeth K ^a   Anderson, Stacie M ^a   Kirby, Martha ^a   Nelson, David L ^b   Candotti, Fabio ^a  

^a NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c KANAZAWA UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

T LYMPHOCYTE RECEPTOR; WISKOTT ALDRICH SYNDROME PROTEIN;

ADOLESCENT; ADULT; ARTICLE; BASE MISPAIRING; BINDING KINETICS; CASE REPORT; CELL SELECTION; DNA EXTRACTION; DOWN REGULATION; FLOW CYTOMETRY; FRAMESHIFT MUTATION; GENE MUTATION; GENE REARRANGEMENT; GENETIC ANALYSIS; GENETIC CODE; HETEROZYGOTE; HUMAN; IMMUNOPHENOTYPING; IN VITRO STUDY; MALE; MOSAICISM; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; REVERTANT; T LYMPHOCYTE; WISKOTT ALDRICH SYNDROME;

EID: 0038665327     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI15485     Document Type: Article

References (38)

1. Ochs, H.D. 1998. The Wiskott-Aldrich syndrome. Springer Semin. Immunopathol. 19:435-458.
2. Derry, J.M., Ochs, H.D., and Francke, U. 1994. Isolation of a novel gene mutated in Wiskott-Aldrich syndrome. Cell. 78:635-644.
3. Stewart, D.M., et al. 1996. Studies of the expression of the Wiskott-Aldrich syndrome protein. J. Clin. Invest. 97:2627-2634.
4. Parolini, O., et al. 1997. Expression of Wiskott-Aldrich syndrome protein (WASP) gene during hematopoietic differentiation. Blood. 90:70-75.
5. Snapper, S.B., and Rosen, F.S. 1999. The Wiskott-Aldrich syndrome protein (WASP): roles in signaling and cytoskeletal organization. Annu. Rev. Immunol. 17:905-929.
6. Kvittingen, E.A., Rootwelt, H., Berger, R., and Brandtzaeg, P. 1994. Self-induced correction of the generic defect in tyrosinemia type I. J. Clin. Invest. 94:1657-1661.
7. Ellis, N.A., et al. 1995. Somatic intragenic recombination within the mutated locus BLM can correct the high sister-chromatid exchange phenotype of Bloom syndrome cells. Am. J. Hum. Genet. 57:1019-1027.
8. Stephan, V., et al. 1996. Atypical X-linked severe combined immunodeficiency due to possible spontaneous reversion of the genetic defect in T cells. N. Engl J. Med. 335:1563-1567.
9. Jonkman, M.F., et al. 1997. Revertant mosaicism in epidermolysis bullosa caused by mitotic gene conversion. Cell. 88:543-551.
10. Lo Ten Foe, J.R., et al. 1997. Somatic mosaicism in Fanconi anemia: molecular basis and clinical significance. Eur. J. Hum. Genet. 5:137-148.
11. Gregory, J.J., Jr., et al. 2001. Somatic mosaicism in Fanconi anemia: evidence of genotypic reversion in lymphohematopoietic stem cells. Proc. Natl. Acad. Sci. U. S. A. 98:2532-2537.
12. Hirschhorn, R., et al. 1996. Spontaneous in vivo reversion to normal of an inherited mutation in a patient with adenosine deaminase deficiency. Nat. Genet. 13:290-295.
13. Ariga, T., et al. 2001. T-cell lines from 2 patients with adenosine deaminase (ADA) deficiency showed the restoration of ADA activity resulted from the reversion of an inherited mutation. Blood. 97:2896-2899.
14. Ariga, T., et al. 2001. Spontaneous in vivo reversion of an inherited mutation in the Wiskott-Aldrich syndrome. J. Immunol. 166:5245-5249.
15. Wada, T., et al. 2001. Somatic mosaicism in Wiskott-Aldrich syndrome suggests in vivo reversion by a DNA slippage mechanism. Proc. Natl. Acad. Sci. U. S. A. 98:8697-8702.
16. Darling, T.N., Yee, C., Bauer, J.W., Hintner, H., and Yancey, K.B. 1999. Revertant mosaicism: partial correction of a germ-line mutation in COL17A1 by a frame-restoring mutation. J. Clin. Invest. 103:1371-1377.
17. Waisfisz, Q., et al. 1999. Spontaneous functional correction of homozygous Fanconi anaemia alleles reveals novel mechanistic basis for reverse mosaicism. Nat. Genet. 22:379-383.
18. Arredondo-Vega, F.X., et al. 2002. Adenosine deaminase deficiency with mosaicism for a "second-site suppressor" of a splicing mutation: decline in revertant T lymphocytes during enzyme replacement therapy. Blood. 99:1005-1013.
19. Levinson, G., and Gutman, G.A. 1987. Slipped-strand mispairing: a major mechanism for DNA sequence evolution. Mol. Biol. Evol. 4:203-221.
20. Darvasi, A., and Kerem, B. 1995. Deletion and insertion mutations in short tandem repeats in the coding regions of human genes. Eur. J. Hum. Genet. 3:14-20.
21. Oron-Karni, V., Filon, D., Rund, D., and Oppenheim, A. 1997. A novel mechanism generating short deletion/insertions following slippage is suggested by a mutation in the human alpha2-globin gene. Hum. Mol. Genet. 6:881-885.
22. Bzymek, M., and Lovett, S.T. 2001. Instability of repetitive DNA sequences: the role of replication in multiple mechanisms. Proc. Natl. Acad. Sci. U. S. A. 98:8319-8325.
23. Pearson, C.E., and Sinden, R.R. 1998. Trinucleotide repeat DNA structures: dynamic mutations from dynamic DNA. Curr. Opin. Struct. Biol. 8:321-330.
24. Zhu, Q., et al. 1995. The Wiskott-Aldrich syndrome and X-linked congenital thrombocytopenia are caused by mutations of the same gene. Blood. 86:3797-3804.
25. Wada, T., Jagadeesh, G.J., Nelson, D.L., and Candotti, F. 2002. Retrovirus-mediated WASP gene transfer corrects Wiskott-Aldrich syndrome T cell dysfunction. Hum. Gene Ther. 13:1039-1046.
26. Candotti, F., et al. 1999. Retrovirus-mediated WASP gene transfer corrects defective actin polymerization in B cell lines from Wiskott-Aldrich syndrome patients carrying 'null' mutations. Gene Ther. 6:1170-1174.
27. Candotti, F., et al. 1997. Structural and functional basis for JAK3-deficient severe combined immunodeficieney. Blood. 90:3996-4003.
28. Assaf, C., et al. 2000. High detection rate of T-cell receptor beta chain rearrangements in T-cell lymphoproliferations by family specific polymerase chain reaction in combination with the GeneScan technique and DNA sequencing. Blood. 96:640-646.
29. Miller, A.D., et al. 1991. Construction and properties of retrovirus packaging cells based on gibbon ape leukemia virus. J. Virol. 65:2220-2224.
30. Treisman, J., et al. 1995. Interleukin-2-transduced lymphocytes grow in an autocrine fashion and remain responsive to antigen. Blood. 85:139-145.
31. Onodera, M., et al. 1998. Development of improved adenosine deaminase retroviral vectors. J. Virol. 72:1769-1774.
32. Kolluri, R., et al. 1995. Identification of WASP mutations in patients with Wiskott-Aldrich syndrome and isolated thrombocytopenia reveals allelic heterogeneity at the WAS locus. Hum. Mol. Genet. 4:1119-1126.
33. Mantuano, E., et al. 1993. Analysis of X-chromosome inactivation in bone marrow precursors from carriers of Wiskott-Aldrich syndrome and X-linked severe combined immunodeficiency: evidence that the Wiskott-Aldrich gene is expressed prior to granulocyte-macrophage colony-forming-unit. Immunodeficiency. 4:271-276.
34. Wengler, G., Gorlin, J.B., Williamson, J.M., Rosen, F.S., and Bing, D.H. 1995. Nonrandom inactivation of the X chromosome in early lineage hematopoietic cells in carriers of Wiskott-Aldrich syndrome. Blood. 85:2471-2477.
35. Fearon, E.R., Kohn, D.B., Winkelstein, J.A., Vogelstein, B., and Blaese, R.M. 1988. Carrier detection in the Wiskott-Aldrich syndrome. Blood. 72:1735-1739.
36. Greer, W.L., et al. 1989. X-chromosome inactivation in the Wiskott-Aldrich syndrome: a marker for detection of the carrier state and identification of cell lineages expressing the gene defect. Genomics. 4:60-67.
37. Kim, A.S., Kakalis, L.T., Abdul-Manan, N., Liu, G.A., and Rosen, M.K. 2000. Autoinhibition and activation mechanisms of the Wiskott-Aldrich syndrome protein. Nature. 404:151-158.
38. Devriendt, K.J., et al. 2001. Constitutively activating mutation in WASP causes X-linked severe congenital neurropenia. Nat. Genet. 27:313-317.